The epigenetics of keloids
- PMID: 34152651
- DOI: 10.1111/exd.14414
The epigenetics of keloids
Abstract
Keloid scarring is a fibroproliferative disorder of the skin with unknown pathophysiology, characterised by fibrotic tissue that extends beyond the boundaries of the original wound. Therapeutic options are few and commonly ineffective, with keloids very commonly recurring even after surgery and adjunct treatments. Epigenetics, defined as alterations to the DNA not involving the base-pair sequence, is a key regulator of cell functions, and aberrant epigenetic modifications have been found to contribute to many pathologies. Multiple studies have examined many different epigenetic modifications in keloids, including DNA methylation, histone modification, microRNAs and long non-coding RNAs. These studies have established that epigenetic dysregulation exists in keloid scars, and successful future treatment of keloids may involve reverting these aberrant modifications back to those found in normal skin. Here we summarise the clinical and experimental studies available on the epigenetics of keloids, discuss the major open questions and future perspectives on the treatment of this disease.
Keywords: epigenetics; histone modification; keloid; methylation; non-coding RNA.
© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
References
REFERENCES
-
- Kelly AP. Medical and surgical therapies for keloids. Dermatol Ther. 2004;17(2):212-218.
-
- Bayat A, McGrouther D, Ferguson M. Skin scarring. BMJ. 2003;326(7380):88-92.
-
- Bran GM, Goessler UR, Hormann K, Riedel F, Sadick H. Keloids: current concepts of pathogenesis. Int J Mol Med. 2009;24(3):283-293.
-
- Supp DM. Animal models for studies of keloid scarring. Adv Wound Care. 2018;8(2):77-89.
-
- Aarabi S, Bhatt KA, Shi Y, et al. Mechanical load initiates hypertrophic scar formation through decreased cellular apoptosis. FASEB J. 2007;21(12):3250-3261.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
